Startup based in France, most recent round Series-c-plus, 5 tracked investors.
Based in France, DNA Script is a startup founded in 2014. Its most recent tracked round is Series-c-plus. Brouky records 5 investors associated with the company.
DNA Script develops and manufactures an enzymatic DNA synthesis technology, enabling on-demand, in-house printing of nucleic acids for life sciences research and development. Their SYNTAX™ platform is an automated benchtop instrument for this purpose.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.